GGrantIndex
← Leaderboards

David V Glidden

University Of California San Francisco

$1,931,701
Attributed
$2,095,856
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $312K · FY201523
$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$2,095,856 · 7

By mechanism

R01$910,589 · 2
U54$649,414 · 2
R03$316,979 · 2
R25$218,874 · 1

Top collaborators

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Hiv Infections

Research focus

Hiv InfectionsCostFutureBiologicalParticipantPersonsResearch PersonnelPharmaceutical PreparationsTenofovirTruvadaOralSafetyClinical TrialsPreventionEmtricitabineSuccessClinical ResearchAdherencePharmacologyPillInsightIncidenceLeadNovel Strategies

Grant awards (16)

Data Management and Biostatistical Analysis Core$180,970
U54 · FY2023 · CA · contact PI
Short Trainings on Methods for Recruiting, Sampling, and Counting Hard-to-Reach Populations: The H2R Training Program$218,874
R25 · FY2022 · MH
Data Management and Biostatistical Analysis Core$86,602
U54 · FY2022 · CA · contact PI
Data Management and Biostatistical Analysis Core$190,921
U54 · FY2021 · CA · contact PI
Statistical methods for clinical trials of novel PrEP agents$121,125
R01 · FY2021 · AI · contact PI
Data Management and Biostatistical Analysis Core$190,921
U54 · FY2020 · CA · contact PI
Statistical methods for clinical trials of novel PrEP agents$121,125
R01 · FY2020 · AI · contact PI
Statistical methods for clinical trials of novel PrEP agents$120,501
R01 · FY2019 · AI · contact PI
Statistical methods for clinical trials of novel PrEP agents$120,063
R01 · FY2018 · AI · contact PI
Comparison of Pharmacologic Markers of Exposure to HIV Pre-Exposure Prophylaxis$79,250
R03 · FY2017 · AI · contact PI
Chemoprophylaxis for HIV Prevention: Analysis of Bone and Metabolic Effects$79,250
R03 · FY2016 · AI · contact PI
Comparison of Pharmacologic Markers of Exposure to HIV Pre-Exposure Prophylaxis$79,250
R03 · FY2016 · AI · contact PI
Chemoprophylaxis for HIV Prevention: Analysis of Bone and Metabolic Effects$79,229
R03 · FY2015 · AI · contact PI
FAILURE TIME METHODS FOR FAMILY DISEASE STUDIES$138,475
R01 · FY2003 · HL
FAILURE TIME METHODS FOR FAMILY DISEASE STUDIES$141,800
R01 · FY2002 · HL
FAILURE TIME METHODS FOR FAMILY DISEASE STUDIES$147,500
R01 · FY2001 · HL